ReachRxResearch
Home
Research
Sign Up
The Era of Precision Medicine: Exacerbation Phenotyping to Determine the Role of Inhaled Corticosteroids in COPD ?
Back to Research Hub
  1. Home
  2. Research Hub
  3. The Era of Precision Medicine: Exacerbat…

The Era of Precision Medicine: Exacerbation Phenotyping to Determine the Role of Inhaled Corticosteroids in COPD ?

Respirology·October 12Open Access
Respiratory SystemPractice changingChronic Obstructive Pulmonary DiseaseReview / CommentaryInhaled CorticosteroidAdultInhaled Corticosteroids

Summary

View source

What was studied

The role of inhaled corticosteroids (ICS) in COPD, examined through the lens of exacerbation phenotyping as a precision medicine approach to guide ICS use.

Key findings

Exacerbation phenotyping (distinguishing eosinophilic vs. non-eosinophilic, infectious vs. non-infectious subtypes) may help identify which COPD patients are most likely to benefit from ICS, potentially reducing overuse and associated harms.

Study limitations

As an editorial or review-type commentary, the paper likely lacks primary trial data, direct patient-level evidence, or head-to-head phenotype-guided ICS trials to confirm clinical recommendations.

Clinical implications

Clinicians should consider the exacerbation phenotype—particularly blood eosinophil levels and exacerbation type—before prescribing or continuing ICS in COPD patients, rather than applying ICS broadly across all COPD.

Caveats

  • No sample size is reported, as this is not a clinical trial or observational cohort study
  • Recommendations around exacerbation phenotyping are not yet validated in prospective, phenotype-guided ICS trials
  • This appears to be an editorial or perspective piece rather than an original research study; conclusions are based on synthesized evidence and expert opinion, not new primary data

Related Questions

Explore related topics

How do blood eosinophil counts guide inhaled corticosteroid use in COPD?What are the risks of inhaled corticosteroids in non-eosinophilic COPD exacerbations?Precision medicine approaches to COPD exacerbation management and phenotyping

Publication Details

Year
2026
Journal
Respirology
Source
View article
Keep scrolling
More content below.
Up Next